papillary RCC

• 

Treatment for hereditary leiomyomatosis renal cell carcinoma (HLRCC): a rare and aggressive form of kidney cancer

By Sharon Kell|2017-04-10T11:46:46+00:0010 Apr 2017|Drug treatments, Subtypes of RCC|

In this video, Dr W. Marston Linehan, chief of the [...]

Read More

Comments Off on Treatment for hereditary leiomyomatosis renal cell carcinoma (HLRCC): a rare and aggressive form of kidney cancer

• 

Savolitinib for papillary renal cell carcinoma

By Sharon Kell|2017-03-08T15:50:04+00:008 Mar 2017|Drug treatments|

Papillary renal cell carcinoma (pRCC) is the second most common [...]

Read More

Comments Off on Savolitinib for papillary renal cell carcinoma

• 

New drug shows promise in kidney cancer in combination with everolimus

By Sharon Kell|2016-12-07T14:32:45+00:007 Dec 2016|Drug treatments|

A new drug that targets a key enzyme that cancer [...]

Read More

Comments Off on New drug shows promise in kidney cancer in combination with everolimus

• 

Everolimus provides some benefit for people with papillary renal cell cancer

By Sharon Kell|2016-10-06T14:43:26+00:006 Oct 2016|Drug treatments|

A study published in the European Journal of Cancer shows that [...]

Read More

Comments Off on Everolimus provides some benefit for people with papillary renal cell cancer

• 

VEGF/mTOR combination for non-clear cell kidney cancer

By Sharon Kell|2016-09-09T08:22:15+00:009 Sep 2016|Drug treatments|

The combination of vascular endothelial growth factor (VEGF)-directed and mammalian [...]

Read More

Comments Off on VEGF/mTOR combination for non-clear cell kidney cancer

Sunitinib vs everolimus for advanced non-clear cell kidney cancer

By Sharon Kell|2016-05-09T08:58:03+00:009 May 2016|Drug treatments|

In a recent study published in the journal Lancet Oncology, [...]

Read More

Comments Off on Sunitinib vs everolimus for advanced non-clear cell kidney cancer